Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 SGD | +8.00% | +17.39% | -10.00% |
May. 13 | AcroMeta Group Swings to Loss in Fiscal H1; Shares Plunge 12% | MT |
May. 13 | AcroMeta Group Enters Preliminary Discussions for Potential Sale of Subsidiary | MT |
Valuation
Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 22.17 | 13.3 | 17.04 | 11.36 | 10.95 | 10.81 |
Enterprise Value (EV) 1 | 16.84 | 9.767 | 18.11 | 17.32 | 19.33 | 15.34 |
P/E ratio | -6.21 x | 440 x | -11.3 x | 131 x | 6.84 x | -1.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.52 x | 0.42 x | 0.74 x | 0.39 x | 0.17 x | 0.16 x |
EV / Revenue | 0.4 x | 0.31 x | 0.78 x | 0.6 x | 0.31 x | 0.22 x |
EV / EBITDA | -5.85 x | 12.6 x | -18.9 x | -208 x | 15 x | 5.27 x |
EV / FCF | -2.73 x | -5.52 x | -8.31 x | -3.2 x | -8.91 x | 2.33 x |
FCF Yield | -36.6% | -18.1% | -12% | -31.3% | -11.2% | 43% |
Price to Book | 3.05 x | 1.82 x | 2.85 x | 1.8 x | 1.49 x | 3.48 x |
Nbr of stocks (in thousands) | 138,564 | 138,564 | 138,564 | 138,564 | 138,564 | 277,128 |
Reference price 2 | 0.1600 | 0.0960 | 0.1230 | 0.0820 | 0.0790 | 0.0390 |
Announcement Date | 1/15/19 | 1/7/20 | 1/12/21 | 1/5/22 | 11/25/22 | 1/14/24 |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 42.31 | 31.9 | 23.1 | 29.1 | 63.26 | 69.5 |
EBITDA 1 | -2.88 | 0.7754 | -0.9587 | -0.0833 | 1.291 | 2.912 |
EBIT 1 | -3.461 | 0.1613 | -1.348 | -0.3535 | 0.848 | 2.549 |
Operating Margin | -8.18% | 0.51% | -5.84% | -1.21% | 1.34% | 3.67% |
Earnings before Tax (EBT) 1 | -3.464 | 0.0277 | -1.541 | -0.5072 | 0.51 | 2.753 |
Net income 1 | -3.425 | 0.0302 | -1.514 | 0.0866 | 1.6 | -6.958 |
Net margin | -8.1% | 0.09% | -6.56% | 0.3% | 2.53% | -10.01% |
EPS 2 | -0.0258 | 0.000218 | -0.0109 | 0.000624 | 0.0115 | -0.0299 |
Free Cash Flow 1 | -6.164 | -1.771 | -2.18 | -5.42 | -2.17 | 6.589 |
FCF margin | -14.57% | -5.55% | -9.44% | -18.62% | -3.43% | 9.48% |
FCF Conversion (EBITDA) | - | - | - | - | - | 226.25% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 1/15/19 | 1/7/20 | 1/12/21 | 1/5/22 | 11/25/22 | 1/14/24 |
Balance Sheet Analysis
Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 1.07 | 5.96 | 8.39 | 4.53 |
Net Cash position 1 | 5.33 | 3.53 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | -1.116 x | -71.57 x | 6.495 x | 1.556 x |
Free Cash Flow 1 | -6.16 | -1.77 | -2.18 | -5.42 | -2.17 | 6.59 |
ROE (net income / shareholders' equity) | -43.8% | 0.47% | -21.6% | -7.9% | 7.09% | 98.6% |
ROA (Net income/ Total Assets) | -9.58% | 0.45% | -3.44% | -0.73% | 1.28% | 3.87% |
Assets 1 | 35.77 | 6.729 | 44.07 | -11.83 | 124.6 | -179.7 |
Book Value Per Share 2 | 0.0500 | 0.0500 | 0.0400 | 0.0500 | 0.0500 | 0.0100 |
Cash Flow per Share 2 | 0.0600 | 0.0600 | 0.0500 | 0.0400 | 0.0400 | 0.0200 |
Capex 1 | 0.62 | 0.23 | 4.73 | 7.22 | 1.61 | 0.85 |
Capex / Sales | 1.46% | 0.71% | 20.47% | 24.82% | 2.55% | 1.22% |
Announcement Date | 1/15/19 | 1/7/20 | 1/12/21 | 1/5/22 | 11/25/22 | 1/14/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-10.00% | 5.85M | |
+1.67% | 71.57B | |
-2.47% | 57.17B | |
+24.94% | 39.18B | |
+21.21% | 33.37B | |
+10.60% | 28.96B | |
+19.89% | 21.87B | |
+12.40% | 19.03B | |
+78.05% | 18.04B | |
+38.51% | 17.8B |
- Stock Market
- Equities
- 43F Stock
- Financials AcroMeta Group Limited